RES-Seq—a barcoded library of drug-resistant Leishmania donovani allowing rapid assessment of cross-resistance and relative fitness
出版年份 2023 全文链接
标题
RES-Seq—a barcoded library of drug-resistant
Leishmania donovani
allowing rapid assessment of cross-resistance and relative fitness
作者
关键词
-
出版物
mBio
Volume -, Issue -, Pages -
出版商
American Society for Microbiology
发表日期
2023-11-06
DOI
10.1128/mbio.01803-23
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial Compound
- (2022) Aya Hefnawy et al. mBio
- Oligo targeting for profiling drug resistance mutations in the parasitic trypanosomatids
- (2022) Simone Altmann et al. NUCLEIC ACIDS RESEARCH
- Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas’ Disease
- (2021) Marta L. Lima et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
- (2021) Charles E. Mowbray et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani
- (2020) Richard J. Wall et al. ACS Infectious Diseases
- Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
- (2020) Advait Nagle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
- (2020) Manuel Saldivia et al. Nature Microbiology
- Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
- (2019) Susan Wyllie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
- (2018) Susan Wyllie et al. NATURE
- Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
- (2018) Victoriano Corpas-Lopez et al. ACS Infectious Diseases
- A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
- (2017) Tom Beneke et al. Royal Society Open Science
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
- (2016) Susan Wyllie et al. PLoS Pathogens
- Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- (2015) Jennifer Riley et al. PLoS Neglected Tropical Diseases
- Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease
- (2015) Shilpi Khare et al. PLoS Pathogens
- Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections
- (2013) ROB DON et al. PARASITOLOGY
- Assessing the Essentiality of Leishmania donovani Nitroreductase and Its Role in Nitro Drug Activation
- (2012) S. Wyllie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started